Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
NS-136 by NeuShen Therapeutics for Alzheimer's Disease: Likelihood of Approval
NS-136 is under clinical development by NeuShen Therapeutics and currently in Phase I for Alzheimer's Disease. According to GlobalData, Phase...
Data Insights
NS-136 by NeuShen Therapeutics for Schizophrenia: Likelihood of Approval
NS-136 is under clinical development by NeuShen Therapeutics and currently in Phase I for Schizophrenia. According to GlobalData, Phase I...